Lipopolysaccharides Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Report
250 Pages
January 2024
Region: Global
Fairfield Market Research
ID: 5924994

The global Lipopolysaccharides (LPS) Immunoassay market has witnessed substantial growth, with worldwide revenue reaching US$ 1.45 billion at the close of 2024. According to a comprehensive report the market is expected to continue its upward trajectory. By the end of 2031, the market is projected to reach US$ 1.9 billion.

Opportunities for Manufacturers:

LPS Detection through Point-of-Care Testing: The market for LPS immunoassays is set for growth driven by the development of point-of-care test kits. This approach finds applications in various industries, including dentistry, where it aids in diagnosing periodontal disease, gum disease, and tooth loss. LPS detection is also crucial for overall body health, with potential links to conditions like cardiovascular and neurodegenerative diseases. The emergence of infectious diseases further fuels the demand for LPS detection, making point-of-care technology a promising avenue for growth.

Challenges Affecting Demand:

Lack of Identified Library for Lipopolysaccharides: The absence of screening assays for multiple LPS antigens limits their use in detection, affecting the accessibility of specific antibodies. Techniques for selecting tailored antibodies need enhancement, and the availability of alternate LPS detection methods hampers market growth.

Country-wise Insights:

U.S. Market: The U.S. LPS immunoassay market is lucrative due to advanced diagnostics availability and rising demand driven by an increase in cancer cases and infectious diseases, including HIV, TB, and influenza.
Germany: Germany's biopharmaceutical industry fuels demand for LPS immunoassays, as established players conduct clinical studies to evaluate biopharmaceutical products for human use.
China: With a large population base, China shows high growth potential in the sales of LPS immunoassay products, driven by the need for efficient infectious disease diagnosis, particularly in response to novel coronavirus infections.

Competitive Landscape:

Major companies in the LPS immunoassay market are actively involved in strategic activities, including mergers and acquisitions, innovative product development, and geographical expansion, to meet the evolving needs of patients.

Key Companies Profiled:

BioChek (BIOTECON Diagnostics)
AdVnt Biotechnologies
Fisher Scientific (THERMO)
Bio-Techne
Response Biomedical
New Horizons Diagnostic Corporation

Key Segments of Lipopolysaccharides Immunoassay Industry Research

Lipopolysaccharides Immunoassay Market by Product Type:

Immunoassay Kits & Reagents
Kits
Primary Antibodies
Secondary Antibodies
Immunoassay Substrates
Immunoassay Buffers
Analysers & Instruments
Consumables
Software

Lipopolysaccharides Immunoassay Market by Assay:

ELISA
FIA
CLIA
LFA
Others

Lipopolysaccharides Immunoassay Market by Purpose:

Research Use Only
Clinical Use

Lipopolysaccharides Immunoassay Market by Application:

Clinical Diagnostics
Drug Discovery
Screening of diseases & disorders

Lipopolysaccharides Immunoassay Market by End User:

Human Use
Veterinary

Lipopolysaccharides Immunoassay Market by Region:

North America Lipopolysaccharides Immunoassay Market
Latin America Lipopolysaccharides Immunoassay Market
Europe Lipopolysaccharides Immunoassay Market
South Asia Lipopolysaccharides Immunoassay Market
East Asia Lipopolysaccharides Immunoassay Market
Oceania Lipopolysaccharides Immunoassay Market
The Middle East & Africa Lipopolysaccharides Immunoassay Market

This product will be delivered within 1-3 business days.

1. Executive Summary

1.1. Global Lipopolysaccharides Immunoassay Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

3.1. Global Lipopolysaccharides Immunoassay Market Production Output, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2023
3.1.1. North America
3.1.2. Europe
3.1.3. Asia Pacific
3.1.4. Latin America
3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

4.1. Global Average Price Analysis, by Product Type/ Material, US$ Per Unit, 2018 - 2023
4.2. Prominent Factor Affecting Breast Tissue Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Lipopolysaccharides Immunoassay Market Outlook, 2018 - 2031

5.1. Global Lipopolysaccharides Immunoassay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Immunoassay Kits & Reagents
5.1.1.1.1. Kits
5.1.1.1.2. Primary Antibodies
5.1.1.1.3. Secondary Antibodies
5.1.1.1.4. Immunoassay Substrates
5.1.1.1.5. Immunoassay Buffers
5.1.1.2. Analysers & Instruments
5.1.1.3. Consumables
5.1.1.4. Software
5.2. Global Lipopolysaccharides Immunoassay Market Outlook, by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. ELISA
5.2.1.2. FIA
5.2.1.3. CLIA
5.2.1.4. LFA
5.2.1.5. Others
5.3. Global Lipopolysaccharides Immunoassay Market Outlook, by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Research Use Only
5.3.1.2. Clinical Use
5.4. Global Lipopolysaccharides Immunoassay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Clinical Diagnostics
5.4.1.2. Drug Discovery
5.4.1.3. Screening of diseases & disorders
5.5. Global Lipopolysaccharides Immunoassay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
5.5.1. Key Highlights
5.5.1.1. Human Use
5.5.1.2. Veterinary
5.6. Global Lipopolysaccharides Immunoassay Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2031
5.6.1. Key Highlights
5.6.1.1. North America
5.6.1.2. Europe
5.6.1.3. Asia Pacific
5.6.1.4. Latin America
5.6.1.5. Middle East & Africa

6. North America Lipopolysaccharides Immunoassay Market Outlook, 2018 - 2031

6.1. North America Lipopolysaccharides Immunoassay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Immunoassay Kits & Reagents
6.1.1.1.1. Kits
6.1.1.1.2. Primary Antibodies
6.1.1.1.3. Secondary Antibodies
6.1.1.1.4. Immunoassay Substrates
6.1.1.1.5. Immunoassay Buffers
6.1.1.2. Analysers & Instruments
6.1.1.3. Consumables
6.1.1.4. Software
6.2. North America Lipopolysaccharides Immunoassay Market Outlook, by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. ELISA
6.2.1.2. FIA
6.2.1.3. CLIA
6.2.1.4. LFA
6.2.1.5. Others
6.3. North America Lipopolysaccharides Immunoassay Market Outlook, by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Research Use Only
6.3.1.2. Clinical Use
6.4. North America Lipopolysaccharides Immunoassay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Clinical Diagnostics
6.4.1.2. Drug Discovery
6.4.1.3. Screening of diseases & disorders
6.5. North America Lipopolysaccharides Immunoassay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.5.1. Key Highlights
6.5.1.1. Human Use
6.5.1.2. Veterinary
6.6. North America Lipopolysaccharides Immunoassay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.6.1. Key Highlights
6.6.1.1. U.S. Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.6.1.2. U.S. Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.6.1.3. U.S. Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.6.1.4. U.S. Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.6.1.5. U.S. Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.6.1.6. Canada Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.6.1.7. Canada Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.6.1.8. Canada Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.6.1.9. Canada Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.6.1.10. Canada Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
6.6.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Lipopolysaccharides Immunoassay Market Outlook, 2018 - 2031

7.1. Europe Lipopolysaccharides Immunoassay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Immunoassay Kits & Reagents
7.1.1.1.1. Kits
7.1.1.1.2. Primary Antibodies
7.1.1.1.3. Secondary Antibodies
7.1.1.1.4. Immunoassay Substrates
7.1.1.1.5. Immunoassay Buffers
7.1.1.2. Analysers & Instruments
7.1.1.3. Consumables
7.1.1.4. Software
7.2. Europe Lipopolysaccharides Immunoassay Market Outlook, by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. ELISA
7.2.1.2. FIA
7.2.1.3. CLIA
7.2.1.4. LFA
7.2.1.5. Others
7.3. Europe Lipopolysaccharides Immunoassay Market Outlook, by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Research Use Only
7.3.1.2. Clinical Use
7.4. Europe Lipopolysaccharides Immunoassay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Clinical Diagnostics
7.4.1.2. Drug Discovery
7.4.1.3. Screening of diseases & disorders
7.5. Europe Lipopolysaccharides Immunoassay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.5.1. Key Highlights
7.5.1.1. Human Use
7.5.1.2. Veterinary
7.6. Europe Lipopolysaccharides Immunoassay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1. Key Highlights
7.6.1.1. Germany Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.2. Germany Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.3. Germany Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.4. Germany Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.5. Germany Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.6. U.K. Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.7. U.K. Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.8. U.K. Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.9. U.K. Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.10. U.K. Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.11. France Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.12. France Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.13. France Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.14. France Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.15. France Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.16. Italy Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.17. Italy Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.18. Italy Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.19. Italy Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.20. Italy Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.21. Turkey Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.22. Turkey Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.23. Turkey Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.24. Turkey Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.25. Turkey Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.26. Russia Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.27. Russia Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.28. Russia Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.29. Russia Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.30. Russia Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.31. Rest of Europe Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.32. Rest of Europe Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.33. Rest of Europe Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.34. Rest of Europe Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.1.35. Rest of Europe Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
7.6.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Lipopolysaccharides Immunoassay Market Outlook, 2018 - 2031

8.1. Asia Pacific Lipopolysaccharides Immunoassay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Immunoassay Kits & Reagents
8.1.1.1.1. Kits
8.1.1.1.2. Primary Antibodies
8.1.1.1.3. Secondary Antibodies
8.1.1.1.4. Immunoassay Substrates
8.1.1.1.5. Immunoassay Buffers
8.1.1.2. Analysers & Instruments
8.1.1.3. Consumables
8.1.1.4. Software
8.2. Asia Pacific Lipopolysaccharides Immunoassay Market Outlook, by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. ELISA
8.2.1.2. FIA
8.2.1.3. CLIA
8.2.1.4. LFA
8.2.1.5. Others
8.3. Asia Pacific Lipopolysaccharides Immunoassay Market Outlook, by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Research Use Only
8.3.1.2. Clinical Use
8.4. Asia Pacific Lipopolysaccharides Immunoassay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Clinical Diagnostics
8.4.1.2. Drug Discovery
8.4.1.3. Screening of diseases & disorders
8.5. Asia Pacific Lipopolysaccharides Immunoassay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.5.1. Key Highlights
8.5.1.1. Human Use
8.5.1.2. Veterinary
8.6. Asia Pacific Lipopolysaccharides Immunoassay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1. Key Highlights
8.6.1.1. China Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.2. China Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.3. China Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.4. China Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.5. China Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.6. Japan Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.7. Japan Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.8. Japan Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.9. Japan Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.10. Japan Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.11. South Korea Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.12. South Korea Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.13. South Korea Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.14. South Korea Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.15. South Korea Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.16. India Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.17. India Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.18. India Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.19. India Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.20. India Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.21. Southeast Asia Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.22. Southeast Asia Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.23. Southeast Asia Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.24. Southeast Asia Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.25. Southeast Asia Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.26. Rest of Asia Pacific Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.27. Rest of Asia Pacific Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.28. Rest of Asia Pacific Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.29. Rest of Asia Pacific Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.1.30. Rest of Asia Pacific Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
8.6.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Lipopolysaccharides Immunoassay Market Outlook, 2018 - 2031

9.1. Latin America Lipopolysaccharides Immunoassay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.1.1. Key Highlights
9.1.1.1. Immunoassay Kits & Reagents
9.1.1.1.1. Kits
9.1.1.1.2. Primary Antibodies
9.1.1.1.3. Secondary Antibodies
9.1.1.1.4. Immunoassay Substrates
9.1.1.1.5. Immunoassay Buffers
9.1.1.2. Analysers & Instruments
9.1.1.3. Consumables
9.1.1.4. Software
9.2. Latin America Lipopolysaccharides Immunoassay Market Outlook, by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.2.1. Key Highlights
9.2.1.1. ELISA
9.2.1.2. FIA
9.2.1.3. CLIA
9.2.1.4. LFA
9.2.1.5. Others
9.3. Latin America Lipopolysaccharides Immunoassay Market Outlook, by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.3.1. Key Highlights
9.3.1.1. Research Use Only
9.3.1.2. Clinical Use
9.4. Latin America Lipopolysaccharides Immunoassay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.4.1. Key Highlights
9.4.1.1. Clinical Diagnostics
9.4.1.2. Drug Discovery
9.4.1.3. Screening of diseases & disorders
9.5. Latin America Lipopolysaccharides Immunoassay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.5.1. Key Highlights
9.5.1.1. Human Use
9.5.1.2. Veterinary
9.6. Latin America Lipopolysaccharides Immunoassay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1. Key Highlights
9.6.1.1. Brazil Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.2. Brazil Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.3. Brazil Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.4. Brazil Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.5. Brazil Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.6. Mexico Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.7. Mexico Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.8. Mexico Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.9. Mexico Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.10. Mexico Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.11. Argentina Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.12. Argentina Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.13. Argentina Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.14. Argentina Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.15. Argentina Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.16. Rest of Latin America Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.17. Rest of Latin America Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.18. Rest of Latin America Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.19. Rest of Latin America Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.1.20. Rest of Latin America Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
9.6.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Lipopolysaccharides Immunoassay Market Outlook, 2018 - 2031

10.1. Middle East & Africa Lipopolysaccharides Immunoassay Market Outlook, by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.1.1. Key Highlights
10.1.1.1. Immunoassay Kits & Reagents
10.1.1.1.1. Kits
10.1.1.1.2. Primary Antibodies
10.1.1.1.3. Secondary Antibodies
10.1.1.1.4. Immunoassay Substrates
10.1.1.1.5. Immunoassay Buffers
10.1.1.2. Analysers & Instruments
10.1.1.3. Consumables
10.1.1.4. Software
10.2. Middle East & Africa Lipopolysaccharides Immunoassay Market Outlook, by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.2.1. Key Highlights
10.2.1.1. ELISA
10.2.1.2. FIA
10.2.1.3. CLIA
10.2.1.4. LFA
10.2.1.5. Others
10.3. Middle East & Africa Lipopolysaccharides Immunoassay Market Outlook, by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.3.1. Key Highlights
10.3.1.1. Research Use Only
10.3.1.2. Clinical Use
10.4. Middle East & Africa Lipopolysaccharides Immunoassay Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.4.1. Key Highlights
10.4.1.1. Clinical Diagnostics
10.4.1.2. Drug Discovery
10.4.1.3. Screening of diseases & disorders
10.5. Middle East & Africa Lipopolysaccharides Immunoassay Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.5.1. Key Highlights
10.5.1.1. Human Use
10.5.1.2. Veterinary
10.6. Middle East & Africa Lipopolysaccharides Immunoassay Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1. Key Highlights
10.6.1.1. GCC Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.2. GCC Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.3. GCC Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.4. GCC Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.5. GCC Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.6. South Africa Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.7. South Africa Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.8. South Africa Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.9. South Africa Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.10. South Africa Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.11. Egypt Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.12. Egypt Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.13. Egypt Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.14. Egypt Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.15. Egypt Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.16. Nigeria Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.17. Nigeria Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.18. Nigeria Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.19. Nigeria Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.20. Nigeria Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.21. Rest of Middle East & Africa Lipopolysaccharides Immunoassay Market by Product Type, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.22. Rest of Middle East & Africa Lipopolysaccharides Immunoassay Market by Assay, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.23. Rest of Middle East & Africa Lipopolysaccharides Immunoassay Market by Purpose, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.24. Rest of Middle East & Africa Lipopolysaccharides Immunoassay Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.1.25. Rest of Middle East & Africa Lipopolysaccharides Immunoassay Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
10.6.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

11.1. Product vs Indication Heatmap
11.2. Company Market Share Analysis, 2023
11.3. Competitive Dashboard
11.4. Company Profiles
11.4.1. BioChek (BIOTECON Diagnostics)
11.4.1.1. Company Overview
11.4.1.2. Product Portfolio
11.4.1.3. Financial Overview
11.4.1.4. Business Strategies and Development
11.4.2. AdVnt Biotechnologies
11.4.2.1. Company Overview
11.4.2.2. Product Portfolio
11.4.2.3. Financial Overview
11.4.2.4. Business Strategies and Development
11.4.3. Fisher Scientific (THERMO)
11.4.3.1. Company Overview
11.4.3.2. Product Portfolio
11.4.3.3. Financial Overview
11.4.3.4. Business Strategies and Development
11.4.4. Bio-Techne
11.4.4.1. Company Overview
11.4.4.2. Product Portfolio
11.4.4.3. Financial Overview
11.4.4.4. Business Strategies and Development
11.4.5. Response Biomedical
11.4.5.1. Company Overview
11.4.5.2. Product Portfolio
11.4.5.3. Financial Overview
11.4.5.4. Business Strategies and Development
11.4.6. New Horizons Diagnostic Corporation
11.4.6.1. Company Overview
11.4.6.2. Product Portfolio
11.4.6.3. Financial Overview
11.4.6.4. Business Strategies and Development

12. Appendix

12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

BioChek(BIOTECON Diagnostics)
AdVnt Biotechnologies
Fisher Scientific (THERMO)
Bio-Techne.
Response Biomedical
New Horizons Diagnostic Corporation

Methodology

LOADING...